Impact of microRNAs on molecular epidemiology;Mikro-RNS-ek jelentosége a molekuláris epidemioló giában

Orvosi Hetilap

Volumn 152, Issue 16, 2011, Pages 633-641

  Gócze, Katalin ^a   Gombos, Katalin ^a   Pajkos, Gábor ^a   Magda, Ingrid ^a   Ember, Ágoston ^a   Juhász, Krisztina ^a   Patczai, Balázs ^a   Ember, István ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

biomarker; cancer; cell free microRNA; microRNA; prevention

Indexed keywords

MICRORNA; UNTRANSLATED RNA;

ARTICLE; MOLECULAR EPIDEMIOLOGY; RNA SEQUENCE;

BIOLOGICAL MARKERS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOLECULAR EPIDEMIOLOGY; NEOPLASMS; PREDICTIVE VALUE OF TESTS; RNA INTERFERENCE; RNA, SMALL UNTRANSLATED; TUMOR MARKERS, BIOLOGICAL;

EID: 79953671109     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2011.29066     Document Type: Article

References (49)

1. Tömböl Zs., Szabó P., Rácz K. és mtsai: A mikro-RNS-ek jelentsége daganatos betegségekben. Orv. Hetil., 2007, 148, 1135-1141. (Pubitemid 47470626)
2. Molnár V., Bakos B., Hegyei H. és mtsa: Nem kódoló genom és mikro-RNS-ek: új fejezet a genetika történetében. LAM, 2008, 18, 591-597.
3. Lawrie, C H., Gal, S., Dunlop, H. M. és mtsai: Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol., 2008, 141, 672-675. (Pubitemid 351667616)
4. Katoh, T., Sakaguchi, Y., Miyauchi, K. és mtsai: Selective stabilization of mammalian microRNAs by 3' adenylation mediated by the cytoplasmic poly (A) polymerase GLD-2. Genes. Dev., 2009, 23, 433-438.
5. Zen, K., Zhang, C Y.: Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med. Res. Rev., 2010. nov. 9. Epub ahead of print.
6. Hunter, M. P., Ismail, N., Zhang, X és mtsai: Detection of micro-RNA expression in human peripheral blood microvesicles. PLoS ONE, 2008, 3, e3694.
7. Ji, X., Takahashi, R., Hiura, Y. és mtsai: Plasma miR-208 as a biomarker of myocardial injury. Clin. Chem., 2009, 55, 1944-1949.
8. Valadi, H., Ekstrom, K., Bossios, A. és mtsai: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell. Biol., 2007, 9, 654-659. (Pubitemid 47214727)
9. Kosaka, N., Iguchi, H., Yoshioka, Y. és mtsai: Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem., 2010, 285, 17442-17452.
10. Mathivanan, S., Ji, H., Simpson, R J.: Exosomes: extracellular organelles important in intercellular communication. J. Proteomics, 2010, 73, 1907-1920.
11. Taylor, D. D., Doellgast, G J.: Quantitation of eroxidise-antibody binding to membrane fragments using column chromatography Anal. Biochem., 1979, 98, 53-59.
12. Taylor, D. D., Gercel-Taylor, C.: MicroRNA signatures of tumorderived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol., 2008, 110, 13-21. (Pubitemid 351853251)
13. Rabinowits, G., Gerçel-Taylor, C., Day, J. M. és mtsai: Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung. Cancer, 2009, 10, 42-46.
14. Skog, J., Wurdinger, T., van Rijn, S. és mtsai: Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell. Biol., 2008, 10, 1470-1476.
15. Valenti, R., Huber, V., Iero, M. és mtsai: Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res., 2007, 67, 2912-2915. (Pubitemid 46724823)
16. Johnson, S. M., Grosshans, H., Shingara, J. és mtsai: RAS is regulated by the let-7 microRNA family Cell, 2005, 120, 635-647. (Pubitemid 40343076)
17. Wurz, K., Garcia, R. L., Goff, B. A. és mtsai: MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival. Genes Chromosomes Cancer, 2010, 49, 577-584.
18. Chun-Zhi, Z., Lei, H., An-Ling, Z. és mtsai: MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer, 2010, 10, 367.
19. Ji, Q, Hao, X., Zhang, M. és mtsai: MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS ONE, 2009, 4, e6816.
20. Zhang, J., Han, L., Ge, Y. és mtsai: miR-221/222 promote malignant progression of glioma through activation of the Akt pathway Int. J. Oncol., 2010, 36, 913-920.
21. Brase, J. C., Wuttig, D., Kuner, R. és mtsa: Serum microRNAs as non-invasive biomarkers for cancer. Mol. Cancer, 2010, 9, 306.
22. Chim, S. S., Shing, T. K., Hung, E. C. és mtsai: Detection and characterization of placental microRNAs in maternal plasma. Clin. Chem., 2008, 54, 482-490. (Pubitemid 351348154)
23. Luo, S. S., Ishibashi, O., Ishikawa, G és mtsai: Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol. Reprod., 2009, 81, 717-729.
24. Adachi, T., Nakanishi, M., Otsuka, Y. és mtsai: Plasma microRNA 499 as a biomarker of acute myocardial Infarction. Clin. Chem., 2010, 56, 1183-1185.
25. Wang, K., Zhang, S., Marzolf, B. és mtsai: Circulating microRNAs, potential biomarkers for drug-induced liver injury Proc Natl. Acad. Sci. USA, 2009, 106, 4402-4407.
26. Wang, J. F., Yu, M. L., Yu, G és mtsai: Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem. Biophys. Res. Commun., 2010, 394, 184-188.
27. Murata, K., Yoshitomi, H., Tanida, S. és mtsai: Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res. Ther., 2010, 12, R86.
28. Tanaka, M., Oikawa, K., Takanashi, M. és mtsai: Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS ONE, 2009, 4, e5532.
29. Ng, E. K., Chong, W W., Jin, H. és mtsai: Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut, 2009, 58, 1375-1381.
30. Bui, T. V., Mendell, J. T.: Myc: Maestro of MicroRNAs. Genes Cancer, 2010, 1, 568-575.
31. Huang, Z., Huang, D., Ni, S. és mtsai: Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer, 2010, 127, 118-126.
32. Wang, J., Chen, J., Chang, P. és mtsai: MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev. Res. (Phila Pa), 2009, 2, 807-813.
33. Lou, Y., Yang, X., Wang, F. és mtsai: MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int. J. Mol. Med., 2010, 26, 819-827.
34. Resnick, K. E., Alder, H., Hagan, J. P. és mtsai: The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol., 2009, 112, 55-59.
35. Ji, J., Shi, J., Budhu, A. és mtsai: MicroRNA expression, survival, and response to interferon in liver cancer. N. Engl. J. Med., 2009, 361, 1437-1447.
36. Hu, Z., Chenm, X., Zhao, Y. és mtsai: Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol., 2010, 28, 1721-1726.
37. Kroh, E. M., Parkin, R. K., Mitchell, P. S. és mtsa: Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods, 2010, 50, 298-301.
38. Chomczynski, P., Sacchi, N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 1987, 162, 156-159. (Pubitemid 17064313)
39. Lusi, E. A, Passamano, M., Guarascio, P. és mtsai: Innovative electrochemical approach for an early detection of microRNAs. Anal. Chem., 2009, 81, 2819-2822.
40. Heneghan, H. M., Miller, N., Kerin, M. J.: Circulating miRNA signatures: promising prognostic tools for cancer. J. Clin. Oncol., 2010, 28, e573-e574.
41. Budhu, A, Ji, J., Wang, X. W.: The clinical potential of microRNAs. J. Hematol. Oncol., 2010, 3, 37.
42. Garzon, R., Marcucci, G, Croce, C. M.: Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov., 2010, 9, 775-789.
43. Mezzanzanica, D., Bagnoli, M., De Cecco, L. és mtsai: Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications. Int. J. Biochem. Cell. Biol., 2010, 42, 1262-1267.
44. Zhou, S. L., Wang, L. D.: Circulating microRNAs: Novel biomar kers for esophageal cancer. World J. Gastroenterol., 2010, 21, 2348-2354.
45. Lin, P. Y., Yu, S. L., Yang, P. C.: MicroRNA in lung cancer. Br. J. Cancer, 2010, 103, 1144-1148.
46. Liu, X., Chen, Z., Yu, J. és mtsai: MicroRNA profiling and head and neck cancer. Comp. Funct. Genomics, 2009, 837514. Epub 2009 Jun 1.
47. Shi, M., Liu, D., Duan, H. és mtsai: Metastasis-related miRNAs, active players in breast cancer invasion and metastasis. Cancer Metastasis Rev., 2010, 29, 785-799.
48. Slaby, O., Svoboda, M., Michalek, J. és mtsa: MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol. Cancer, 2009, 8, 102.
49. Heneghan, H. M., Miller, N., Kerin, M. J.: MiRNAs as biomarkers and therapeutic targets in cancer. Curr. Opin. Pharmacol., 2010, 10, 543-550.